ArticleslgStudy

biology

Glanzmann's thrombasthenia

Glanzmann's thrombasthenia is a biology topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Glanzmann's thrombasthenia rather than just read about it. In short: Glanzmann's thrombasthenia is an abnormality of the platelets. It is an extremely rare coagulopathy (bleeding disorder due to a blood abnormality), in which the platelets contain defective or low levels of glycoprotein IIb/IIIa (GpIIb/IIIa), which is a receptor for fibrinogen.

Glanzmann's thrombasthenia — main illustration
Glanzmann's thrombasthenia — illustration

Key takeaways

  • Glanzmann's thrombasthenia belongs to biology; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect Glanzmann's thrombasthenia to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of Glanzmann's thrombasthenia from memory before moving on to harder problems.

Reference excerpt

Glanzmann's thrombasthenia is an abnormality of the platelets. It is an extremely rare coagulopathy (bleeding disorder due to a blood abnormality), in which the platelets contain defective or low levels of glycoprotein IIb/IIIa (GpIIb/IIIa), which is a receptor for fibrinogen. As a result, no fibrinogen bridging of platelets to other platelets can occur, and the bleeding time is significantly prolonged.

Signs and symptoms Characteristically, there is increased mucosal bleeding:

heavy menstrual bleeding easy bruising nosebleeds Bleeding from the gums gastrointestinal bleeding postpartum bleeding increased postoperative bleeding. The bleeding tendency is variable but may be severe. Bleeding into the joints, particularly spontaneous bleeds, are very rare, in contrast to the hemophilias. Platelet numbers and morphology are normal. Platelet aggregation is normal with ristocetin, but impaired with other agonists such as ADP, thrombin, collagen, or epinephrine.

Cause Glanzmann's thrombasthenia can be inherited in an autosomal recessive manner or acquired as an autoimmune disorder. The bleeding tendency in Glanzmann's thrombasthenia is variable, some individuals having minimal bruising, while others have frequent, severe, potentially fatal hemorrhages. Moreover, platelet αIIbβ3 levels correlate poorly with hemorrhagic severity, as virtually undetectable αIIbβ3 levels can correlate with negligible bleeding symptoms, and 10–15% levels can correlate with severe bleeding. Unidentified factors other than the platelet defect itself may have important roles.

Pathophysiology Glanzmann's thrombasthenia is associated with abnormal integrin αIIbβ3, formerly known as glycoprotein IIb/IIIa (GpIIb/IIIa), which is an integrin aggregation receptor on platelets. This receptor is activated when the platelet is stimulated by ADP, epinephrine, collagen, or thrombin. GpIIb/IIIa is essential to blood coagulation since the activated receptor has the ability to bind fibrinogen (as well as von Willebrand factor, fibronectin, and vitronectin), which is required for fibrinogen-dependent platelet-platelet interaction (aggregation). Understanding of the role of GpIIb/IIIa in Glanzmann's thrombasthenia led to the development of GpIIb/IIIa inhibitors, a class of powerful antiplatelet agents.

Diagnosis Light transmission aggregometry is widely accepted as the gold standard diagnostic tool for assessing platelet function, and a result of absent aggregation with any agonist except ristocetin is highly specific for Glanzmann's thrombasthenia. Following is a table comparing its result with other platelet aggregation disorders:

Treatment Therapy involves both preventive measures and treatment of specific bleeding episodes.

Dental hygiene lessens gingival bleeding Avoidance of antiplatelet agents such as aspirin and other anti-inflammatory drugs (NSAIDs) such as ibuprofen and naproxen, and anticoagulants Iron or folate supplementation may be necessary if excessive or prolonged bleeding has caused anemia Hepatitis B vaccine Antifibrinolytic drugs such as tranexamic acid or ε-aminocaproic acid (Amicar) Desmopressin (DDAVP) does not normalize the bleeding time in Glanzmann's thrombasthenia but anecdotally improves hemostasis Hormonal contraceptives to control excessive menstrual bleeding Topical agents such as gelfoam, fibrin sealants, polyethylene glycol polymers, custom dental splints Platelet transfusions (only if bleeding is severe; risk of platelet alloimmunization) Recombinant factor VIIa, AryoSeven or NovoSeven FDA approved this drug for the treatment of the disease in July 2014. Hematopoietic stem cell transplantation (HSCT) for severe recurrent hemorrhages

Eponym It is named after Eduard Glanzmann (1887–1959), the Swiss pediatrician who originally described it.

History The subsequent studies, following Eduard Glanzmann's description of hemorrhagic symptoms and "weak platelets", demonstrated that these patients have prolonged bleeding times and their platelets failed to aggregate in response to activation. In the mid-1970s, Nurden and Caen and Phillips and colleagues discovered that thrombasthenic platelets are deficient in integrins αIIbβ3.

See also Bernard-Soulier syndrome

References

External links

Illustrations

Glanzmann's thrombasthenia illustration

Worked examples

Example 1 — a first encounter with Glanzmann's thrombasthenia

Start with the simplest possible case. Write down what Glanzmann's thrombasthenia claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In biology, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Glanzmann's thrombasthenia before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Glanzmann's thrombasthenia ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Glanzmann's thrombasthenia

In research
Glanzmann's thrombasthenia appears in biology research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses Glanzmann's thrombasthenia in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
Glanzmann's thrombasthenia is common in secondary-school and first-year university syllabi. It links to neighbouring topics Autosomal recessive disorders, Coagulopathies, Rare diseases, so understanding it makes those chapters shorter.
In everyday life
Look for Glanzmann's thrombasthenia outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.
Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Glanzmann's thrombasthenia” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Glanzmann's thrombasthenia in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what Glanzmann's thrombasthenia means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain Glanzmann's thrombasthenia out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Glanzmann's thrombasthenia in simple terms?

Glanzmann's thrombasthenia is an abnormality of the platelets. It is an extremely rare coagulopathy (bleeding disorder due to a blood abnormality), in which the platelets contain defective or low levels of glycoprotein IIb/IIIa (GpIIb/IIIa), which is a receptor for fibrinogen.

Why does Glanzmann's thrombasthenia matter?

Because it connects several biology ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Glanzmann's thrombasthenia?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Glanzmann's thrombasthenia.

Tags

  • Autosomal recessive disorders
  • Coagulopathies
  • Rare diseases

Keep exploring